Employer-Paid

Findings of the new Lockton 2026 National Benefits Survey indicate that 46% of self-funded plan sponsors say they would consider international drug sourcing for pharmacy benefits, an approach that remains complex and may expose plan sponsors to legal and compliance risks if not properly designed and administered.

Holders would have 180 days to replace the arrangements or liquidate them.

Public sentiment toward insurers has deteriorated sharply with just 17% of voters report a favorable view of health insurance companies.

Out-of-pocket spending for covered drugs would count toward a patient's maximum out-of-pocket and deductible regardless of where such drugs are purchased under the Every Dollar Counts Act introduced by Rep. Greg Murphy, R-N.C.

The key in 2026 is to take a strategic, data-driven approach to employee benefits, designing programs that are both affordable and personalized to support employees and also attracting and retaining talent.

The benefits giant's health revenue climbed 6%, but career revenue fell 2%.